These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15564451)

  • 81. Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.
    Ye L; Bu Z; Vzorov A; Taylor D; Compans RW; Yang C
    J Virol; 2004 Dec; 78(24):13409-19. PubMed ID: 15564451
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain.
    Bu Z; Ye L; Vzorov A; Taylor D; Compans RW; Yang C
    Virology; 2004 Oct; 328(1):62-73. PubMed ID: 15380359
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.
    Quiñones-Kochs MI; Buonocore L; Rose JK
    J Virol; 2002 May; 76(9):4199-211. PubMed ID: 11932385
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
    Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
    DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparative immunogenicity of human immunodeficiency virus particles and corresponding polypeptides in a DNA vaccine.
    Akahata W; Yang ZY; Nabel GJ
    J Virol; 2005 Jan; 79(1):626-31. PubMed ID: 15596858
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.
    Day JR; Münk C; Guatelli JC
    J Virol; 2004 Feb; 78(3):1069-79. PubMed ID: 14722262
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Enhancement of immune responses to an HIV env DNA vaccine by a C-terminal segment of listeriolysin O.
    Bu Z; Ye L; Skeen MJ; Ziegler HK; Compans RW; Yang C
    AIDS Res Hum Retroviruses; 2003 May; 19(5):409-20. PubMed ID: 12803999
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Modifications of the human immunodeficiency virus envelope glycoprotein enhance immunogenicity for genetic immunization.
    Chakrabarti BK; Kong WP; Wu BY; Yang ZY; Friborg J; Ling X; King SR; Montefiori DC; Nabel GJ
    J Virol; 2002 Jun; 76(11):5357-68. PubMed ID: 11991964
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Influence of human immunodeficiency virus type 1 envelope glycoprotein YXXL endocytosis/polarization signal on viral accessory protein functions.
    Cervantes-Acosta G; Lodge R; Lemay G; Cohen EA
    J Hum Virol; 2001; 4(5):249-59. PubMed ID: 11907382
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
    West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
    J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.
    Bültmann A; Muranyi W; Seed B; Haas J
    J Virol; 2001 Jun; 75(11):5263-76. PubMed ID: 11333908
    [TBL] [Abstract][Full Text] [Related]  

  • 93. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell.
    Geleziunas R; Xu W; Takeda K; Ichijo H; Greene WC
    Nature; 2001 Apr; 410(6830):834-8. PubMed ID: 11298454
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter].
    Wyss S; Berlioz-Torrent C; Boge M; Blot G; Höning S; Benarous R; Thali M
    J Virol; 2001 Mar; 75(6):2982-92. PubMed ID: 11222723
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Endocytosis in viral replication.
    Marsh M; Pelchen-Matthews A
    Traffic; 2000 Jul; 1(7):525-32. PubMed ID: 11208139
    [TBL] [Abstract][Full Text] [Related]  

  • 96. In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail.
    Fultz PN; Vance PJ; Endres MJ; Tao B; Dvorin JD; Davis IC; Lifson JD; Montefiori DC; Marsh M; Malim MH; Hoxie JA
    J Virol; 2001 Jan; 75(1):278-91. PubMed ID: 11119598
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Palmitoylation of the HIV-1 envelope glycoprotein is critical for viral infectivity.
    Rousso I; Mixon MB; Chen BK; Kim PS
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13523-5. PubMed ID: 11095714
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.